Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
56
Number of overlapping holdings
16.2%
% of FHLC's 369 holdings also in WDNA
63.6%
% of WDNA's 91 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 2.1% | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.0% | 1.6% | 1.6% |
|
REGENERON PHARMACEUTICALS | 1.8% | 1.4% | 1.4% |
|
AMGEN INC | 2.8% | 1.4% | 1.4% |
|
DANAHER CORP | 3.0% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to WDNA
|
UNITEDHEALTH GROUP INC | 8.3% |
|
ELI LILLY & CO | 8.2% |
|
ABBVIE INC | 5.2% |
|
JOHNSON & JOHNSON | 5.0% |
|
MERCK & CO. INC. | 3.8% |
|
ABBOTT LABORATORIES | 2.9% |
|
THERMO FISHER SCIENTIFIC INC | 2.5% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
ELEVANCE HEALTH INC | 1.9% |
|
PFIZER INC | 1.8% |
FHLC Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -4.3% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
BLUEPRINT MEDICINES CORP. | -2.5% |
|
GERON CORP | -2.5% |
|
AGIOS PHARMACEUTICALS INC | -2.3% |
|
FATE THERAPEUTICS INC | -2.2% |
|
VERICEL CORPORATION | -2.1% |
|
NATERA INC | -2.0% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.7% |
|
BRIDGEBIO PHARMA, INC. | -1.6% |